Form 8-K - Current report:
SEC Accession No. 0001140361-20-000658
Filing Date
2020-01-13
Accepted
2020-01-13 06:01:55
Documents
3
Period of Report
2020-01-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 22159
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 21708
3 image0.jpg GRAPHIC 12481
  Complete submission text file 0001140361-20-000658.txt   62312
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 20522622
SIC: 2834 Pharmaceutical Preparations